로딩 중…
지수 로딩 중…
BridgeBio Pharma, Inc.
BBIO· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$66.27-1.66%
2026-06-18
Price Chart
BridgeBio Pharma, Inc.+65.67%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $12.98B |
| Revenue | $580M |
| Net Income | $-726M |
| Total Assets | $1.37B |
| Net Assets | $-2.27B |
| Value | |
| P/S | 22.38x |
| FCF Yield | -3.50% |
| Profitability | |
| ROA | -52.95% |
| Op. Margin | -98.40% |
| Revenue Growth | 66.78% |
| Financial Health | |
| Total Debt | $3.38B |
| FCF | $-454M |
| Cash | $880M |
| Current Ratio | 1.44x |
| Performance | |
| 1Y Return | 65.67% |
| 1M Return | 0.41% |
| From 52W High | -21.98% |
| 1Y MDD | -20.25% |
| Trading | |
| Volume | 3,504,702 shares |
| Trading Value | $234M |
| Per Share | |
| EPS | $-3.70 |